Abbott Laboratories has posted a sharp jump in net profits. This is mainly due to improved operating efficiencies and a 33% decline in interest expenditure. The company has also registered an increase in margins to 5.7% on the back of these factors.
(Rs m) | 2QFY2000 | 2QFY1999 | Change |
Net Sales | 505 | 466 | 8.3% |
Other Income | 1 | 2 | -27.4% |
Expenditure | 463 | 433 | 7.1% |
Interest | 10 | 15 | -33.1% |
Depreciation | 4 | 4 | 1.7% |
Profit before Tax | 29 | 17 | 70.6% |
Tax | - | - | NM |
Profit after Tax | 29 | 17 | 73.0% |
Net profit margin | 5.7% | 3.6% |
Sorry! There are no related views on news for this company/sector.
Ajit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More
Equitymaster requests your view! Post a comment on "Abbott Lab posts 73% jump in net". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!